mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0003 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0003 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0003 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0004 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0004 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0004 |